Since tirzepatide often produces less nausea at equivalent efficacy, switching may provide the same weight loss with better GI tolerance
In total, 94% ( n = 302) of participants completed the trial (that is, accomplished the final trial visit), and 89% ( n = 285) completed treatment
They want to see documented evidencenotes from your doctor, logs from a program, etc
The parent trials primary endpoint was change in visceral adipose tissue, with secondary cardiometabolic and body-composition endpoints
As more of these drugs come online, thats more and more what were going to have to do, to figure out where the benefit is biggest. Kidney health The more we look into it, the more we realise cardiovascular outcomes are really highly linked in with kidney disease as well, says Helen ONeil, senior medicines optimisation pharmacist in Tees Valley